-+ 0.00%
-+ 0.00%
-+ 0.00%

Maxim Group Initiates Coverage On Kazia Therapeutics with Buy Rating, Announces Price Target of $3

Benzinga·02/06/2025 23:41:41
Listen to the news
Maxim Group analyst Jason McCarthy initiates coverage on Kazia Therapeutics (NASDAQ:KZIA) with a Buy rating and announces Price Target of $3.